- Home
- MTEX vs SNSE Comparison
MTEX vs SNSE Comparison
Compare MTEX & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- SNSE
- Stock Information
- Founded
- MTEX 1993
- SNSE 2005
- Country
- MTEX United States
- SNSE United States
- Employees
- MTEX N/A
- SNSE N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- MTEX Health Care
- SNSE Health Care
- Exchange
- MTEX Nasdaq
- SNSE Nasdaq
- Market Cap
- MTEX 14.2M
- SNSE 12.3M
- IPO Year
- MTEX 1999
- SNSE 2021
- Fundamental
- Price
- MTEX $7.99
- SNSE $0.47
- Analyst Decision
- MTEX
- SNSE Strong Buy
- Analyst Count
- MTEX 0
- SNSE 3
- Target Price
- MTEX N/A
- SNSE $4.33
- AVG Volume (30 Days)
- MTEX 2.2K
- SNSE 894.4K
- Earning Date
- MTEX 11-12-2024
- SNSE 11-14-2024
- Dividend Yield
- MTEX N/A
- SNSE N/A
- EPS Growth
- MTEX N/A
- SNSE N/A
- EPS
- MTEX N/A
- SNSE N/A
- Revenue
- MTEX $121,552,000.00
- SNSE N/A
- Revenue This Year
- MTEX N/A
- SNSE N/A
- Revenue Next Year
- MTEX N/A
- SNSE N/A
- P/E Ratio
- MTEX N/A
- SNSE N/A
- Revenue Growth
- MTEX N/A
- SNSE N/A
- 52 Week Low
- MTEX $6.75
- SNSE $0.38
- 52 Week High
- MTEX $10.51
- SNSE $1.94
- Technical
- Relative Strength Index (RSI)
- MTEX 52.49
- SNSE 50.56
- Support Level
- MTEX $7.50
- SNSE $0.52
- Resistance Level
- MTEX $8.52
- SNSE $0.59
- Average True Range (ATR)
- MTEX 0.30
- SNSE 0.05
- MACD
- MTEX -0.04
- SNSE 0.00
- Stochastic Oscillator
- MTEX 57.78
- SNSE 48.19
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.